A weekly dose for a year and a half has been shown to reduce weight by 21% in obese people
The administration of the antibody mavrilimumab in conjunction with prednisone reduces the risk of exacerbation of symptoms of the disease and improv1
Researchers from the Hospital Clínic-IDIBAPS and the CIBERSAM participate in a study that evidences the involvement of numerous genes in the developm1
Studies have shown that this drug improves sleep and daytime performance in people with insomnia, without causing a sedative effect the next day, as1
Researchers from the Hospital Clínic-IDIBAPS are leading a study to obtain information on 10,000 healthy people who do not have Parkinson's disease,1
This award, worth 35,000 euros, recognises the researcher’s contribution to clinical research in diet and nutrition.
The deadline for applications is the 28th August and 2 of the 15 fellows will be hired by IDIBAPS.
The causal relationship between the TLR7 gene mutation and lupus paves the way for an effective cure
The visit is part of a new communication project aimed at raising awareness of the research carried out at the Institute among patients and patient a1
The partnership aims to improve current characterization and research practices of this disease.